• JS Bio and Etta Biotech Advancing Partnership contractpharma
    January 20, 2021
    ​Jianshun Biosciences (JS Bio) recently formed its strategic partnership with Etta Biotech to set up a high titer transient protein expression platform for high quality protein production using JS Bio’s transient transfection media.
PharmaSources Customer Service